Interestingly, as these studies highlight, the role of HO-1 and cell fate is context and cell type-dependent which require careful considering in predicting and understanding how to most effectively exploit the HO-1 axis for therapeutic gain in the treatment of cancer. This evidence concerns the gene HMOX1 and cancer.